ClearPoint Neuro market cap CLPT
Share price times shares outstanding: what the whole company sells for, since 2012.
- Today, Oct 23, 2026
- $278.8M
- Highest close in our data
- $778.3M
- Oct 2025
ClearPoint Neuro is worth $278.8M at the close on Oct 23, 2026, at $9.14 a share.
That is down 60% over the last year and down 25% over five years.
Its highest close in our data was $778.3M in Oct 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $278.8M | $257.5M | $561.4M | −30% |
| 2025 | $398.5M | $279.9M | $778.3M | −8% |
| 2024 | $434.5M | $141.9M | $434.5M | +160% |
| 2023 | $167.2M | $109.8M | $261M | −20% |
| 2022 | $208M | $188.8M | $401.4M | −22% |
| 2021 | $265.2M | $264M | $489M | −1% |
| 2020 | $268.1M | $47.8M | $268.1M | +250% |
| 2019 | $76.5M | $24.2M | $76.5M | +311% |
| 2018 | $18.6M | $15.3M | $36.3M | −35% |
| 2017 | $28.6M | $6.8M | $31.5M | +133% |
| 2016 | $12.3M | $7.7M | $37.6M | −57% |
| 2015 | $28.5M | $28.5M | $97.3M | −44% |
| 2014 | $51.3M | $43M | $87.1M | −34% |
| 2013 | $77.8M | $61.9M | $94.8M | +1% |
| 2012 | $76.8M | $44.1M | $141.6M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest ClearPoint Neuro's size, closest first, today.
| Company | Market cap |
|---|---|
| CLPTClearPoint Neuro | $278.8M |
| INFUInfuSystem | $277.6M |
| UTMDUtah Medical Products | $236.3M |
| EMBCEmbecta | $380.2M |
| PDEXPro DEX | $199.3M |
| TCMDTactile Systems Technology | $535.5M |
| MDXGMimedx | $569.9M |
| MOVMovado | $701.9M |
| KEQUKewaunee Scientific | $94.9M |
| IRMDIradimed | $1.1B |
| STAAStaar Surgical | $1.1B |
| Peer median | $457.8M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on ClearPoint Neuro
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.